All 258 BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Holdings
There are 258 BIB holdings. Top 10 companies weight: 60.91%.
Total Market Cap: $1.73T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (258 stocks) | +18.25% | 21.12 | 15.77 | 0.45 | +26.32% | +9.60% | 0.75 | ||||||||||
51 | ABVX | Abivax Sa Adr | 0.30% | $134.09 | $11B | Biotechnology | Healthcare | +25.56% | N/A | N/A | N/A | N/A | N/A | 84 | +20.07% | $161 | 0.00% | 1.85 |
52 | RYTM | Rhythm Pharmaceuticals Inc | 0.30% | $106.60 | $7.51B | Biotechnology | Healthcare | +17.00% | N/A | N/A | N/A | N/A | N/A | 79 | +31.08% | $140 | +40.62% | 0.88 |
53 | SYRE | Spyre Therapeutics Inc | 0.30% | $102.70 | $8.05B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +1.20% | $104 | -9.05% | 1.75 |
54 | MIRM | Mirum Pharmaceuticals Inc | 0.29% | $117.05 | $7.37B | Biotechnology | Healthcare | -34.51% | N/A | 2000.00 | N/A | N/A | N/A | 82 | +25.16% | $147 | +49.35% | 0.84 |
55 | PTCT | Ptc Therapeutics Inc | 0.26% | $78.50 | $6.53B | Biotechnology | Healthcare | -16.59% | N/A | 56.50 | 0.81 | N/A | N/A | 75 | +22.20% | $96 | +13.28% | 0.99 |
56 | COGT | Cogent Biosciences Inc | 0.26% | $39.64 | $6.71B | Biotechnology | Healthcare | -15.32% | N/A | N/A | N/A | N/A | N/A | 75 | +36.86% | $54 | +42.82% | 1.71 |
57 | TWST | Twist Bioscience Corp | 0.25% | $95.86 | $5.76B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 77 | -7.68% | $89 | -4.63% | 2.04 |
58 | SRRK | Scholar Rock Holding Corp | 0.25% | $50.88 | $6.44B | Biotechnology | Healthcare | +5.29% | N/A | N/A | N/A | N/A | N/A | 79 | +16.57% | $59 | +9.01% | 0.67 |
59 | LGND | Ligand Pharmaceuticals Inc | 0.25% | $305.47 | $5.93B | Biotechnology | Healthcare | +26.59% | 37.91 | 34.01 | 1.53 | N/A | N/A | 80 | +1.91% | $311 | +20.10% | 0.96 |
60 | CGON | Cg Oncology Inc | 0.24% | $71.72 | $6.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +25.89% | $90 | 0.00% | 1.46 |
61 | XENE | Xenon Pharmaceuticals Inc | 0.23% | $66.74 | $6.54B | Biotechnology | Healthcare | +40.27% | N/A | N/A | N/A | N/A | N/A | 78 | +20.71% | $81 | +29.69% | 0.92 |
62 | ERAS | Erasca Inc | 0.22% | $19.38 | $5.51B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +17.65% | $23 | -0.63% | 1.38 |
63 | ORKA | Oruka Therapeutics Inc | 0.22% | $94.32 | $4.35B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +53.38% | $145 | +32.89% | N/A |
64 | TVTX | Travere Therapeutics Inc Ordinary Shares | 0.21% | $56.58 | $5.24B | Biotechnology | Healthcare | -44.12% | N/A | 77.52 | N/A | N/A | N/A | 76 | +3.15% | $58 | +34.24% | 1.28 |
65 | AMRX | N/A | 0.21% | $18.10 | $5.44B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 54.57 | 6.30 | N/A | N/A | N/A | 87 | +0.83% | $18 | +30.35% | 0.89 |
66 | CRSP | Crispr Therapeutics Ag | 0.21% | $48.15 | $4.95B | Biotechnology | Healthcare | +2.10% | N/A | 23.36 | N/A | N/A | N/A | 70 | +79.04% | $86 | -17.34% | 1.44 |
67 | CAI | Caris Life Sciences Inc | 0.21% | $15.73 | $4.94B | Biotechnology | Healthcare | N/A | N/A | 43.29 | N/A | N/A | N/A | 71 | +71.65% | $27 | 0.00% | 1.42 |
68 | DFTX | N/A | 0.19% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
69 | INDV | N/A | 0.19% | $40.45 | $5.08B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 25.96 | 13.28 | N/A | N/A | N/A | 83 | +25.66% | $51 | +30.84% | 0.72 |
70 | VCYT | Veracyte Inc | 0.19% | $59.53 | $4.75B | Diagnostics & Research | Healthcare | N/A | 53.71 | 34.36 | 0.34 | N/A | N/A | 70 | -5.01% | $57 | +9.24% | 1.36 |
71 | TXG | N/A | 0.18% | $47.20 | $5.87B | Health Information Services | Healthcare | N/A | N/A | 714.29 | N/A | N/A | N/A | 60 | -15.57% | $40 | -23.98% | 2.05 |
72 | ACAD | Acadia Pharmaceuticals Inc | 0.17% | $25.43 | $4.43B | Biotechnology | Healthcare | N/A | 11.73 | 76.34 | 0.19 | N/A | N/A | 72 | +28.39% | $33 | +2.73% | 0.90 |
73 | EWTX | Edgewise Therapeutics Inc | 0.17% | $39.58 | $4.39B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +26.12% | $50 | +14.06% | 1.37 |
74 | CRNX | Crinetics Pharmaceuticals Inc | 0.16% | $83.90 | $8.84B | Biotechnology | Healthcare | +16.22% | N/A | N/A | N/A | N/A | N/A | 78 | -1.67% | $83 | +33.64% | 1.02 |
75 | TNGX | Tango Therapeutics Inc | 0.16% | $29.02 | $4.36B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +52.76% | $44 | +21.99% | 1.40 |
76 | GPCR | Structure Therapeutics Inc Adr | 0.16% | $49.35 | $3.53B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +111.94% | $105 | 0.00% | 0.83 |
77 | DNLI | Denali Therapeutics Inc | 0.16% | $23.83 | $3.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +43.73% | $34 | -18.07% | 1.46 |
78 | NAMS | Newamsterdam Pharma Co Nv | 0.16% | $32.34 | $3.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +53.71% | $50 | 0.00% | 1.02 |
79 | RLAY | Relay Therapeutics Inc Ordinary Shares | 0.15% | $19.30 | $3.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +31.50% | $25 | -10.84% | 1.84 |
80 | DYN | Dyne Therapeutics Inc Ordinary Shares | 0.14% | $23.83 | $3.96B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +64.50% | $39 | +4.50% | 1.77 |
81 | ADPT | Adaptive Biotechnologies Corp | 0.14% | $22.58 | $3.66B | Diagnostics & Research | Healthcare | -22.53% | N/A | N/A | N/A | N/A | N/A | 78 | -2.57% | $22 | -9.75% | 1.71 |
82 | ARQT | N/A | 0.13% | $28.26 | $3.47B | Biotechnology | Healthcare | -58.89% | N/A | 158.73 | N/A | N/A | N/A | N/A | N/A | N/A | +2.52% | N/A |
83 | ALMS | Alumis Inc | 0.13% | $30.05 | $3.60B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +33.44% | $40 | 0.00% | 0.88 |
84 | BEAM | Beam Therapeutics Inc | 0.13% | $27.29 | $3.17B | Biotechnology | Healthcare | -36.45% | N/A | N/A | N/A | N/A | N/A | 73 | +91.68% | $52 | -22.11% | 1.82 |
85 | VERA | Vera Therapeutics Inc Class A | 0.12% | $37.17 | $3.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +120.04% | $82 | +17.52% | 1.22 |
86 | IDYA | Ideaya Biosciences Inc | 0.12% | $35.99 | $3.23B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +45.29% | $52 | +10.10% | 1.11 |
87 | RARE | Ultragenyx Pharmaceutical Inc | 0.12% | $28.62 | $3.12B | Biotechnology | Healthcare | +15.22% | N/A | N/A | N/A | N/A | N/A | 78 | +83.54% | $53 | -19.29% | 0.97 |
88 | ELVN | Enliven Therapeutics Inc | 0.12% | $54.33 | $3.24B | Biotechnology | Healthcare | -7.13% | N/A | N/A | N/A | N/A | N/A | 75 | +21.48% | $66 | +19.34% | 1.17 |
89 | QURE | Uniqure Nv | 0.11% | $40.09 | $2.58B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 75 | +61.39% | $65 | +8.64% | 0.99 |
90 | KNSA | N/A | 0.11% | $63.55 | $4.72B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 68.37 | 58.14 | N/A | N/A | N/A | 78 | +7.19% | $68 | +35.04% | 0.55 |
91 | SUPN | Supernus Pharmaceuticals Inc | 0.11% | $47.87 | $2.77B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 20.16 | 1.47 | N/A | N/A | 75 | +32.65% | $64 | +11.88% | 0.49 |
92 | GRAL | Grail Inc | 0.11% | $72.71 | $3.06B | Diagnostics & Research | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 61 | -3.56% | $70 | 0.00% | 2.23 |
93 | IRON | Disc Medicine Inc Ordinary Shares | 0.11% | $75.58 | $2.90B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +34.36% | $102 | +8.36% | 1.15 |
94 | BCRX | Biocryst Pharmaceuticals Inc | 0.10% | $9.42 | $2.39B | Drug Manufacturers - Specialty & Generic | Healthcare | +6.24% | N/A | 86.96 | N/A | N/A | N/A | N/A | N/A | N/A | -11.11% | N/A |
95 | NRIX | Nurix Therapeutics Inc Ordinary Shares | 0.10% | $23.48 | $2.47B | Biotechnology | Healthcare | +10.31% | N/A | N/A | N/A | N/A | N/A | 81 | +38.42% | $33 | -5.21% | 1.36 |
96 | MBX | Mbx Biosciences Inc | 0.10% | $60.28 | $2.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +14.47% | $69 | 0.00% | 1.44 |
97 | TRVI | Trevi Therapeutics Inc | 0.10% | $18.18 | $2.33B | Biotechnology | Healthcare | -27.09% | N/A | N/A | N/A | N/A | N/A | 80 | +36.96% | $25 | +55.03% | 0.66 |
98 | LEGN | Legend Biotech Corp Adr | 0.10% | $23.54 | $4.26B | Biotechnology | Healthcare | -13.49% | N/A | 149.25 | N/A | N/A | N/A | 80 | +136.32% | $56 | -13.66% | 0.49 |
99 | TARS | N/A | 0.10% | $57.26 | $2.47B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +65.14% | $95 | +17.34% | 0.62 |
100 | ABCL | Abcellera Biologics Inc Ordinary Shares | 0.09% | $5.97 | $2.05B | Biotechnology | Healthcare | N/A | N/A | 27.55 | N/A | N/A | N/A | 75 | +75.88% | $11 | -17.93% | 1.66 |
BIB (PROSHARES ULTRA NASDAQ BIOTECHNOLOGY) Sector Allocation
HEALTHCARE
53.00%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%